Format

Send to

Choose Destination
Clin Gastroenterol Hepatol. 2014 Feb;12(2):289-91. doi: 10.1016/j.cgh.2013.10.009. Epub 2013 Oct 20.

What is the value of a food and drug administration investigational new drug application for fecal microbiota transplantation to treat Clostridium difficile Infection?

Author information

1
Division of Gastroenterology and Nutrition, Department of Medicine, Loyola University Chicago-Stritch School of Medicine, Chicago, Illinois.
2
Departments of Medicine and Microbiology, Department of Veterans Affairs Medical Center, New York University Langone Medical Center, New York, New York.
3
Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St Louis, Missouri.
4
Obesity, Metabolism and Nutrition Institute, Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts.
5
Howard Hughes Medical Institute, Departments of Chemistry and Biochemistry and Computer Science, BioFrontiers Institute, University of Colorado at Boulder, Boulder, Colorado.
6
Section of Digestive Diseases, Yale University School of Medicine, New Haven, Connecticut; VA Connecticut Healthcare System, West Haven, Connecticut.
7
Division of Gastroenterology, Vanderbilt University, Nashville, Tennessee.
8
International Scientific Association for Probiotics and Prebiotics, Davis, California.
9
Departments of Medicine, Microbiology and Immunology, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
10
Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
11
Department of Medicine, Stony Brook University School of Medicine, Stony Brook, New York.
PMID:
24148361
DOI:
10.1016/j.cgh.2013.10.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center